Business Context and Reporting Period
This Form 8-K was filed by McKesson Corporation on November 13, 2013, with the earliest event reported on that date. The filing details amendments to existing credit facilities and bridge loan agreements entered into between November 13 and November 15, 2013, primarily to accommodate the acquisition of Celesio AG.
Key Financial Metrics and Agreements
- Credit Agreement: A syndicated $1.3 billion five-year senior unsecured Credit Agreement (dated September 23, 2011) was amended.
- Receivables Purchase Agreement: The Fourth Amended and Restated Receivables Purchase Agreement (dated May 18, 2011) was amended.
- Bridge Loan Agreement: A $5.5 billion 364-day unsecured Bridge Loan Agreement (dated October 23, 2013) was amended.
- Covenant Adjustment: The maximum debt-to-capital ratio covenant for both the Credit Agreement and the Receivables Purchase Agreement was increased from 56.5% to 65%.
- Liquidity Extension: The facility termination date for the Receivables Purchase Agreement was extended from November 15, 2013, to November 14, 2014.
Material Changes and Operational Context
The primary material change involves the relaxation of financial covenants and the addition of specific cure periods related to the acquisition of Celesio AG. The amendments introduce a cure period for defaults relating to Celesio or its subsidiaries. This period begins on the closing date of the Bridge Term Loan Agreement and ends on the later of 90 days from closing or 60 days following the discovery of a default by a responsible officer. Additionally, the Bridge Loan Agreement was amended to clarify closing conditions regarding the provision of Celesio's financial statements.
Guidance, Outlook, and Risks
The filing does not provide specific revenue guidance, profit outlook, or management commentary on future performance. The primary risk addressed is the potential for covenant defaults associated with the Celesio acquisition, which is now mitigated by the newly established cure periods and increased debt-to-capital ratio limits. The filing notes that the descriptions of the amendments are qualified by reference to the executed agreements attached as exhibits.
Investor Verification Checklist
- Verify the execution of Amendment No. 1 to the Credit Agreement (Exhibit 10.1) and Amendment No. 3 to the Receivables Purchase Agreement (Exhibit 10.2).
- Confirm the specific terms of the cure period regarding Celesio AG defaults.
- Review the clarified closing conditions in Amendment No. 1 to the Bridge Loan Agreement (Exhibit 10.3).
- Monitor the company's debt-to-capital ratio to ensure compliance with the new 65% threshold.